钼靶X射线摄片与血清CA15-3、CEA和OPN联检对乳腺癌的临床诊断价值  

Clinical Diagnostic Value of Molybdenum Target X-ray Combined with Serum CA15-3,CEA and OPN in the Detection of Breast Cancer

作　　者：葛玉兵 刘海燕[1] 史硕达 

机构地区：[1]江苏省泗阳县人民医院普外科,223700

出　　处：《放射免疫学杂志》2013年第1期28-30,共3页Journal of Radioimmanology

摘　　要：目的:探讨乳腺钼靶X射线摄片与血清CA15-3、CEA和OPN联检对乳腺癌的临床诊断价值。方法:对36例经手术和病理证实的乳腺癌患者的血清CA15-3、CEA、OPN检测结果和乳腺钼靶X射线征象作回顾性统计分析。结果:乳腺癌患者血清CA15-3、CEA、OPN水平均非常显著地高于正常人组(P<0.01),血清CA15-3、CEA、OPN和钼靶X射线摄片联检的敏感性较单独检查有显著提高(P<0.01)。结论:对乳腺癌患者进行血清CA15-3、CEA、OPN联检和钼靶X射线摄片检查可提高其阳性检出率。对早期诊断、治疗和监视、随访有重要的临床价值。Objective Methods To explore the clinical diagnostic value of CR molybdenum target X-ray combined with serum CA15-3, CEA and OPN in detection of breast cancer. Methods There were 36 cases of breast cancer confirmed by surgery and pa- thology, the results of CA15-3, CEA, OPN and the signs of molybdenum target X-ray were statistical analyzed retrospectively. Results Serum CA15-3, CEA and OPN levels in patients with breast cancer were significantly higher than those in controls （P 〈 0.01 ）. The sensitivity of serum CA15-3, CEA and OPN combined with molybdenum target X-ray was better than any one of them（P 〈0.01 ）. The combined detection of serum CA15-3, CEA, OPN and molybdenum target X-ray in breast cancer patients can improve the detective rate . Conclusion Molybdenum target X-ray combined with serum CA15-3, CEA and OPN in detection of breast cancer. It play an important role in early diagnosis, treatment and monitoring.

关 键 词：乳腺癌 钼靶X射线摄片 癌胚抗原 糖类抗原15-3 骨桥蛋白 

分 类 号：R737.9[医药卫生—肿瘤]